AtriCure (NASDAQ: ATRC) director exercises 25,000 options and sells 25,000 shares
Rhea-AI Filing Summary
AtriCure director Sven Wehrwein exercised 25,000 non-qualified stock options at an exercise price of $19.95 per share on July 28, 2026, converting them into 25,000 shares of common stock. The same day, he sold 25,000 shares at a weighted average price of $37.84 per share in multiple trades between $37.73 and $39.04. Following the exercise, no options remain outstanding under this specific grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
3 txns
Insider
WEHRWEIN SVEN
Role
Director
Sold
25,000 shs ($946K)
Approx. gross sale proceeds
$946K
Approx. exercise cost
$499K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Non-qualified Stock Option (right to buy) F2 | 25,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 25,000 | $19.95 | $499K |
| Sale | Common Stock F1 | 25,000 | $37.84 | $946K |
Holdings After Transaction:
Non-qualified Stock Option (right to buy) — 0 shares (Direct);
Common Stock — 40,518 shares (Direct)
Footnotes (2)
- F1. This transaction was executed in multiple trades at prices ranging from $37.73 to $39.04 per share. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2. These options were granted on November 11, 2016. These options vest and are exercisable as to 25% of the shares one year from the date of grant and the remaining 75% thereafter vests and are exercisable in equal monthly installments on the same day of the month over the following three years.
Key Figures
Options exercised: 25,000 shares
Exercise price: $19.95 per share
Shares sold: 25,000 shares
+5 more
8 metrics
Options exercised
25,000 shares
Non-qualified stock options exercised on 2026-07-28
Exercise price
$19.95 per share
Exercise price of non-qualified stock options
Shares sold
25,000 shares
Common stock sold on 2026-07-28 following option exercise
Weighted average sale price
$37.84 per share
Weighted average price across multiple sale trades
Sale price range
$37.73–$39.04 per share
Range of prices for multiple trades in the sale transaction
Options remaining under grant
0 shares
Non-qualified stock option grant balance after 25,000-share exercise
Option grant date
November 11, 2016
Original grant date of the non-qualified stock options
Option expiration date
November 11, 2026
Expiration date of the exercised non-qualified stock options
Key Terms
Non-qualified Stock Option, weighted average sales price, Exercise or conversion of derivative security, multiple trades
4 terms
Non-qualified Stock Option financial
"Non-qualified Stock Option (right to buy)"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
weighted average sales price financial
"The price reported above reflects the weighted average sales price."
Exercise or conversion of derivative security financial
"transaction_code_description: Exercise or conversion of derivative security"
multiple trades financial
"This transaction was executed in multiple trades at prices ranging"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did AtriCure (ATRC) director Sven Wehrwein report in this Form 4?
Sven Wehrwein reported exercising 25,000 stock options at $19.95 per share and selling 25,000 common shares at a weighted average price of $37.84 on July 28, 2026.
How many AtriCure (ATRC) options did Sven Wehrwein exercise and at what price?
He exercised 25,000 non-qualified stock options at an exercise price of $19.95 per share. These options were originally granted in 2016 and fully vested under a four-year vesting schedule.
Did Sven Wehrwein retain any AtriCure (ATRC) options from this specific grant?
No. After exercising 25,000 options associated with this grant, the reported remaining option balance under this non-qualified stock option grant is 0 shares, indicating it has been fully exercised.
What is the background of the AtriCure (ATRC) options Sven Wehrwein exercised?
The options were granted November 11, 2016, with 25% vesting after one year and the remaining 75% vesting monthly over the next three years, becoming fully exercisable before the reported 2026 exercise.